Pain after cesarean section.
Conditions
Interventions
Intervention 1: In the intervention group: gabapentin, 300 mg capsule, oral, single dose, Mehr Pharmaceutical Company. Intervention 2: In the control group: placebo, oral, single dose, capsule.
Treatment - Drugs
Placebo
In the intervention group: gabapentin, 300 mg capsule, oral, single dose, Mehr Pharmaceutical Company
In the control group: placebo, oral, single dose, capsule
Sponsors
Vice Chancellor for research of sabzevar University of Medical Science
Eligibility
Sex/Gender
Female
Age
77 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients who were willing to participate in the study and signed an informed consent letter; age 18 and above; Pregnancy age between 37 and 42 weeks? Term pregnancy; Having a live and monolingual fetus; Auxillary tempreture less than 37.5 degrees; Pfannenstiel incision in the previous cesarean section; Elective cesarean; Spinal anesthesia; No history of seizure; No history of gabapentin susceptibility; No history of psychiatric disorders; No Infectious Disease AIDS and hepatitis; Absence of uncontrolled blood pressure and diabetes; No systemic disease to moderate to severe; No alcohol and drug addiction. Exclusion criteria: Patient's lack of cooperation; Analgesic use 8 hours before surgery; Use of non-steroidal anti-inflammatory drugs 24 hours before surgery; Need for general anesthetic.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain after cesarean section. Timepoint: 6 times in recovery and at hours 2, 4, 6, 12, 24 after cesarean section. Method of measurement: Visual Scale of Pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactM.s Sara Hajiseyedi
Sabzevar University of Medical Sciences
Outcome results
None listed